The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBYOT.L Regulatory News (BYOT)

  • There is currently no data for BYOT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Equity

1 Nov 2006 07:01

Byotrol PLC01 November 2006 BYOTROL PLC Placing to raise £5 million to accelerate growth The Board of Byotrol plc (the "Company") is pleased to announce that CharlesStanley Securities has, on behalf of the Company, completed a placing (the"Placing") of 8.34 million new Ordinary Shares of 0.25p each (the "PlacingShares") at 60 pence per share to raise approximately £4.6 million, net ofexpenses. The funds will be used by the Directors to address an increasing number ofopportunities that have been recently identified in the Company's target marketsof Healthcare, Food Processing and Industrial & Technical. The Company recently obtained CE Marking status approving Byotrol for sale inmedical and disinfectant products in Europe and approval from the US EnvironmentProtection Agency for Byotrol to be used as a disinfectant, sanitiser and anti-microbial product in a broad number of market sectors. As a result the Companyhas been approached by several major multinationals interested in gaining accessto the Company's technology and the Company is currently engaged in discussionswith a number of these companies regarding the sale and/or licensing of Byotrol.It is expected that the placing proceeds will assist the progress of suchdiscussions. The Placing Shares will, when issued and fully paid, rank pari passu in allrespects with the existing issued ordinary shares of the Company. The Placing is not a rights issue or open offer and the Placing Shares will notbe offered generally to Shareholders, whether on a pre-emptive basis orotherwise. The Directors believe that the considerable extra cost and delayinvolved in a rights issue or open offer would not be in the best interests ofthe Company in the circumstances. Richard Bell, a consultant to the Company, has acquired 10,000 Placing Shares,pursuant to the Placing, and accordingly now owns 10,000 Ordinary Shares in theCompany. Application has been made for the Placing Shares to be admitted to trading onAIM and trading in the Placing Shares is expected to commence on Tuesday 7November 2006. Following the admission of the Placing Shares to trading on AIM,the Company will have 43,212,849 Ordinary Shares in issue. Charles Stanley Securities has also placed a further 1,500,000 ordinary shareson behalf of Mr Ragnar Olaffson, representing 4.30 per cent. of the currentissued share capital, with institutional investors at a price of 60p. Followingthis, Mr Olaffson holds 1,298,000 ordinary shares, representing 3.72 per cent.of the current issued share capital and 3.00 per cent. of the issued sharecapital as enlarged by the Placing. 1 November 2006 Enquiries: Byotrol plc 0161 277 9518 Stephen FalderDeputy Chairman David McRobbieChief Executive Charles Stanley Securities 020 7149 6457 Philip Davies First City PR 0207 436 7486 Allan Piper McCann Erickson PR 01625 822540 Jim Rothnie This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
30th Apr 20247:00 amRNSCancellation - Byotrol Plc
29th Apr 20242:15 pmRNSSecondary Trading on Asset Match
23rd Apr 20246:00 pmRNSByotrol
22nd Apr 20244:44 pmRNSCapital Reorganisation Delay
22nd Apr 20241:27 pmRNSResults of General Meeting
15th Apr 202411:48 amRNSHolding(s) in Company
8th Apr 20247:00 amRNSHolding(s) in Company
2nd Apr 20243:27 pmRNSDirector Dealing
28th Mar 20247:00 amRNSProposed Cancellation
22nd Dec 202311:44 amRNSHolding(s) in Company
7th Dec 20237:00 amRNSHalf-year Report
14th Nov 20237:00 amRNSLaunch of PROCESSUS® Instrument Decontamination
14th Nov 20237:00 amRNSTrading Update
9th Nov 20233:43 pmRNSHolding(s) in Company
27th Sep 20237:00 amRNSBoard Changes
13th Sep 20233:33 pmRNSResult of AGM
8th Sep 20234:33 pmRNSDirector Dealing
7th Sep 20237:01 amRNSBoard Appointment
7th Sep 20237:00 amRNSTrading Update
29th Aug 20238:51 amRNSLaunch of CHEMGENE MEDLAB into human healthcare
23rd Aug 20237:00 amRNSInvestor Presentation via Investor Meet Company
31st Jul 20237:00 amRNSFinal Results
6th Jul 20237:00 amRNSPatent Grant for Novel Anti-viral Seaweed Extract
24th May 20233:14 pmRNSUS EPA approves Byotrol24 as long-lasting virucide
24th May 20238:51 amRNSDirector Dealing
28th Apr 20239:57 amRNSDirector Dealing
27th Apr 20237:00 amRNSTrading Update and Board Changes
1st Feb 20239:52 amRNSDirector Dealing
22nd Dec 20223:08 pmRNSDirector Dealing
19th Dec 202210:00 amRNSDirector Dealing
16th Dec 20227:00 amRNSGrant of Share Incentive Awards
12th Dec 20227:00 amRNSInterim results and Investor Presentation
22nd Nov 20227:00 amRNSDirectorate Changes
27th Sep 202211:15 amRNSPDMR Shareholding
22nd Sep 20225:21 pmRNSResult of AGM
8th Sep 20227:00 amRNSDirector Dealing
2nd Sep 202210:02 amRNSInvestor Presentation
30th Aug 20227:00 amRNSFinal Results
12th Aug 20223:30 pmRNSDirector Dealing
28th Jul 20227:00 amRNSCompletion of Convertible Loan Note Fundraising
11th Jul 20227:00 amRNSTrading Update and Notice of Results
22nd Apr 20229:14 amRNSHolding(s) in Company
2nd Mar 20227:00 amRNSTrading Update
12th Jan 20227:00 amRNSSenior Management Appointment
14th Dec 20219:06 amRNSSecond Price Monitoring Extn
14th Dec 20219:00 amRNSPrice Monitoring Extension
13th Dec 20217:00 amRNSDirectorate Change
9th Dec 20218:51 amRNSDirector Dealing
8th Dec 20217:00 amRNSInterim Results and Investor Presentation
2nd Nov 20217:00 amRNSDirectorate and Senior Management Changes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.